Tempus AI generates revenue primarily through two core segments: Diagnostics and Data & Applications. Its Diagnostics division commercializes genomic, molecular, and hereditary testing kits, alongside advanced oncology assays sold directly to hospitals, clinics, and physicians. Its Data and Applications segment monetizes anonymized clinical and molecular datasets through data licensing agreements, software analytics platforms, artificial intelligence modeling tools, and collaborative research partnerships with major global pharmaceutical enterprises.